31
Views
6
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

The Effect of Long-Term Ethanol Feeding on Efficacy of Doxycycline plus Rifampicin in the Treatment of Experimental Brucellosis Caused by Brucella melitensis in Rats

Pages 509-513 | Published online: 18 Jul 2013

References

  • Sternbach GL. Infections in alcoholic patients. Emerg Med Clin North Am 1990; 8 (4): 793–803.
  • Davis CC, Mellencamp MA, Preheim LC. A model of pneumococcal pneumonia in chronically intoxicated rats. J Infect Dis 1991; 163 (4): 799–805.
  • Dornand J, Gross A, Lafont V, Liautard J, Oliaro J, Liautard JP. The innate immune response against Brucella in humans. Vet Microbiol 2002; 90 (1-4): 383–94.
  • Corbel MJ. Brucellosis: an overview. Emerg Infect Dis 1997; 3 (2): 213–21.
  • Young EJ. An overview of human brucellosis. Clin Infect Dis 1995; 21 (2): 283–9.
  • Madkour MM. Brucellosis: overview. In: Madkour MM, eds. Madkour's Brucellosis. 2cd ed. Germany: Springer. 2001: 1-15.
  • Young EJ. Brucella species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Disease. 6th ed. New York: Churchill Livingstone. 2005: 2669–74.
  • Shasha B, Lang R, Rubinstein E. Therapy of experimen-tal murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin. Antimicrob Agents Chemother 1992; 36 (5): 973–6.
  • Arya OP, Alergant CD, Annels EH, Carey PB, Ghosh AK, Goddard AD. Management of non-specific urethritis in men. Evaluation of six treatment regimens and effect of other factors including alcohol and sexual intercourse. Br J Vener Dis 1978; 54 (6): 414–21.
  • Grassi CC, Grassi C. Ethanol-antibiotic interactions at hepatic level. Int J Clin Pharmacol Biopharm 1975; 11 (3): 216–25.
  • Akvardar Y, Turkcan A, Yazman U, Aytaclar S, Ergor G, Cakmak D. Prevalence of alcohol use in Istanbul. Psychol Rep 2003; 92 (3 Pt 2): 1081-8.
  • Yumuk Z, Ozdemirci S, Erden BF, Dundar V. The effect of long-term ethanol feeding on Brucella melitensis infection of rats. Alcohol Alcohol 2001; 36 (4): 314–7.
  • Uzbay IT, Kayaalp SO. A modified liquid diet of chron-ic ethanol administration: validation by ethanol withdrawal syn-drome in rats. Pharmacol Res 1995; 31 (1): 37–42.
  • Kumar N, Cow JG. Residual solvent analysis by head-space gas chromatography. J Chromatogr A 1994; 667 (1-2): 235–40.
  • Gram-negative facultatively anaerobic bacilli and aerobic coccobacilli. In: Baron JE, Peterson LR, Finegold SM, eds. Bailey & Scott's Diagnostic Microbiology. 9th ed. Missouri, USA: Mosby. 1994: 406-428.
  • Shasha B, Lang R, Rubinstein E. Efficacy of combina-tions of doxycycline and rifampicin in the therapy of experi-mental mouse brucellosis. J Antimicrob Chemother 1994; 33 (3): 545–51.
  • Klassen M, Edberg SC. Measurement of antibiotics in human body fluids: techniques and significance. In: Lorian V, eds. Antibiotics in laboratory medicine. 4th ed. Baltimore, Maryland USA: Williams & Wilkins. 1996: 230–295.
  • Jerrells TR, Sibley D. Effects of ethanol on cellular immunity to facultative intracellular bacteria. Alcohol Clin Exp Res 1995; 19 (1): 11–6.
  • Miscellaneous fastidious gram-negative bacilli. In: Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC, eds. Diagnostic Microbiology. 5th ed. Philadelphia: J. B. Lippincott. 1997: 395–472.
  • Solera J, Martinez-Alfaro E, Espinosa A. Recognition and optimum treatment of brucellosis. Drugs 1997; 53 (2): 245–56.
  • Neuvonen PJ, Penttila O, Roos M, Tirkkonen J. Effect of long-term alcohol consumption on the half-life of tetracy-cline and doxycycline in man. Int J Clin Pharmacol Biopharm 1976; 14 (4): 303–7.
  • Mattila MJ, Laisi U, Linnoila M, Salonen R. Effect of alcoholic beverages on the pharmacokinetics of doxycycline in man. Acta Pharmacol Toxicol 1982; 50 (5): 370–3.
  • Preheim LC, Olsen KM, Yue M, Snitily MU, Gentry MJ. Ethanol feeding does not affect the efficacy or pharmaco-kinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia. Alcohol Clin Exp Res 1999; 23 (5): 842–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.